Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
about
PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilitiesDelivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancerLanthanide probes for bioresponsive imagingComplex gadolinium-oxo clusters formed along concave protein surfacesBasic MR relaxation mechanisms and contrast agent designDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersMolecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsNew clathrin-based nanoplatforms for magnetic resonance imagingEmerging MRI methods in translational cardiovascular researchNanoparticles for imaging: top or flop?Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agentGd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.Macromolecular Imaging Agents Containing Lanthanides: Can Conceptual Promise Lead to Clinical Potential?Is macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.Modulating water-exchange rates of lanthanide(III)-containing polyaminopolycarboxylate-type complexes using polyethylene glycol.Physicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agentDysprosium complexes and their micelles as potential bimodal agents for magnetic resonance and optical imaging.A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.New calcium-selective smart contrast agents for magnetic resonance imaging.Micellar self-assemblies of gadolinium(III)/europium(III) amphiphilic complexes as model contrast agents for bimodal imaging.B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.Redox- and hypoxia-responsive MRI contrast agents.Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agentsNanoparticles based on star polymers as theranostic vectors: endosomal-triggered drug release combined with MRI sensitivity.Biocompatible nanoparticles of KGd(H₂O)₂[Fe(CN)₆]·H₂O with extremely high T₁-weighted relaxivity owing to two water molecules directly bound to the Gd(III) centerStructural, optical and sensing properties of novel Eu(III) complexes with furan- and pyridine-based ligands.MR imaging probes: design and applications.Critical design issues in the targeted molecular imaging of cell surface receptors.Assembly of near infra-red emitting upconverting nanoparticles and multiple Gd(III)-chelates as a potential bimodal contrast agent for MRI and optical imaging.A pH-Responsive MRI Agent that Can Be Activated Beyond the Tissue Magnetization Transfer Window.A water-soluble and water-coordinated Mn(II) complex: synthesis, characterization and phantom MRI image study.Tuning of the sensing properties of luminescent Eu(3+) complexes towards the nitrate anion.Magnetofluorescent micelles incorporating Dy(III)-DOTA as potential bimodal agents for optical and high field magnetic resonance imaging.Interaction of Gd-DTPA with phosphate and phosphite: toward the reaction intermediate in nephrogenic systemic fibrosis.Amphiphilic Ditopic Bis-Aqua Gd-AAZTA-like Complexes Enhance Relaxivity of Lipidic MRI Nanoprobes.Europium-directed self-assembly of a luminescent supramolecular gel from a tripodal terpyridine-based ligand.Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging.Alternatives to gadolinium-based metal chelates for magnetic resonance imagingActivation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters
P2860
Q24594884-20C464C3-8DBC-451D-84A0-E5E2EE57F772Q24614491-6E9EAF60-4F1C-419D-A278-5C42919E605DQ27000361-7E758948-02AD-40C4-836F-8CE12C369AB6Q27682075-F7535797-200C-44CA-B697-5E1CF496AA5BQ27692546-F24C8AF5-3E83-40ED-B6FB-EFB129A68BFFQ28235682-B62A46D7-0397-44BF-ADBA-24DACCFCAB2CQ28283802-80C38BEC-3256-4CEE-ADF0-8A5F1360EE0DQ28304646-D22EBADD-844F-4655-B826-8C3001B97D1EQ28483110-54172854-1275-47B4-945E-CFE6D980B335Q30425743-59148095-C251-414B-BC07-275143A4A5DDQ30429119-4774AF10-301B-4912-B9A0-4231816CA621Q30576125-B152D3A3-4D86-4857-AEC4-7E7E11E53F33Q30577667-1E2DDA6E-416B-4F2B-BEF9-24B95AB91260Q30596925-69E0D576-131A-429E-8AE3-AA8B50470CADQ30604750-6CAE0E8E-A61A-4D6E-B16D-A4AA842DCD95Q30616187-C0106117-82CB-4F51-BC6A-E959908DC917Q30661518-93861D71-EA89-4C82-A276-A0763BA61E8DQ30677097-E2E30C7A-6CE5-49A5-8774-CD5AAA91966AQ30678244-B68FD358-0E51-4AFA-BAB8-02EE1230090FQ30718946-F32A9FE5-4DAF-4CCD-9E1A-4E027ADF8F38Q30729090-5CCCFA3E-1E87-40B5-ABBB-68C0BADF077DQ30752868-E86A501D-F864-4F5A-AF7B-A06420787486Q30820031-C0D63837-F2D6-4A2A-BAC6-B3C8CBA070ABQ30830645-8DE9F4AE-6AAD-46C7-A5AB-F8468F72CAEDQ30834488-B083C739-7885-4495-974B-6B868226D78AQ30853878-2BFD5D83-13D9-48E3-9BD9-977FCAE65A02Q30867617-CCF45E1A-811B-4CAA-9311-26E9ED868929Q30868199-D594CDCD-EE5D-4DA4-89EF-BEE669A479C1Q30899036-1ADE31F3-A3EE-4A75-944D-88E9A81232D9Q30958749-681464B2-6471-42E1-89E9-79C905ABDEEBQ30975694-5EB48EDC-9ACF-4020-BA68-78C058B69889Q30978230-950D67C2-9DEB-4C17-9ED0-31956925DC8EQ31037775-4A1F308A-5283-4ABF-BDE9-AEF5743AE823Q31044226-F62BADCF-067F-40BF-AD9E-715E87E891F9Q31048535-664B406C-D6C7-45F5-B1CF-97A103648B20Q31109393-E1C7E7F5-E5DD-4145-9525-01EDA78C8DCCQ33353736-C3CE3D62-F788-4456-80EE-96755A99017BQ33555204-A94F6E3F-AB48-4CE6-AA45-BD9EAEF094C1Q33557361-338DB656-8C01-4EE2-ACB5-D47ED8189414Q33590028-FAE1AA88-05DC-42CF-BA98-8D5401B39AF9
P2860
Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@ast
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@en
type
label
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@ast
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@en
prefLabel
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@ast
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@en
P356
P1476
Protein-targeted gadolinium-ba ...... esign and mechanism of action.
@en
P304
P356
10.1021/AR800220P
P407
P577
2009-07-01T00:00:00Z